Seh Jong Park

Reduced Dose of Imatinib for Patients with Chronic Myeloid Leukemia and Low Body Surface Area

H. Y. Seo, S. Oh, Jun Suk Kim, 2007, Acta Haematologica.

Human feeder cells can support the undifferentiated growth of human and mouse embryonic stem cells using their own basic fibroblast growth factors.

J. H. Kim, Y. Yoo, Yong Park, 2011, Stem cells and development.

Treatment results including more than third-line chemotherapy for patients with advanced non-small cell lung cancer.

H. Y. Seo, S. Oh, Jun Suk Kim, 2010, Oncology letters.

High-dose Immunoglobulin Infusion for Thrombotic Thrombocytopenic Purpura Refractory to Plasma Exchange and Steroid Therapy

H. Y. Seo, Jun Suk Kim, S. Kim, 2008, The Korean journal of internal medicine.

First-Line Dasatinib Plus Conventional Chemotherapy in Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Interim Analysis of the Korean Prospective Phase II Study

Jin Seok Kim, H. Yhim, Yoo-Jin Kim, 2011 .

Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

C. Choi, H. Eom, H. Yhim, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Hepatitis B virus reactivation in a surface antigen-negative and antibody-positive patient after rituximab plus CHOP chemotherapy.

Yong Park, S. Kim, D. Kim, 2008, Cancer research and treatment : official journal of Korean Cancer Association.

Prevalence of and Factors Associated with Malignancy in Males with Iron-Deficiency Anemia

Jung Sun Kim, Yong Park, C. Choi, 2014 .

Glucose transporter-1 expression in squamous cell carcinoma of the tongue.

Jun Suk Kim, Yeul-Hong Kim, K. Jung, 2007, Cancer research and treatment : official journal of Korean Cancer Association.